OVA is widely used as a model allergen to study IgE-mediated hypersensitivity and food allergy. Numerous studies have mapped partial T and B cell epitopes of OVA using mouse models and sera from allergic patients. The analysis of IgE-binding epitopes in mice offers potential strategies for the design of specific immunotherapies. In addition, research on peptide OVA323-339 is providing insights into the role of T helper cells in allergic inflammation and antibody production. Other OVA peptide research holds promise for the development of peptide-based vaccines, the creation of hypoallergenic molecules and the determination of cross-reactivity between food allergens.

Creative Diagnostics offers a wide range of antibodies against OVA epitope peptides (aa 61-68, aa 191-202, aa 257-264, aa 323-339, aa 363-374, etc.) to facilitate scientific research. These antibodies target widely reported epitopes or epitopes similar to human patient IgE epitopes. Tailored to a wide range of applications, these products can be conjugated with different labels to meet specific research needs. By employing these cutting-edge antibodies, researchers can accelerate their investigations and make significant advances in the field of immunology.